Augsburg Longitudinal Plasma Study for the Evaluation of Liquid Biopsy as Diagnostic Tool.
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital Augsburg
About this trial
A prospective observational trial of patients with metastatic cancer of various entities which aims at both clarifying the significance of liquid biopsy and establishing a foundation for translational research.
Eligibility criteria
Qualifiers
Written informed consent
Age ≥ 18 years
Histopathologically confirmed metastatic or locally advanced cancer
No curative treatment options, except for germ cell tumors
Disqualifiers
Psychological condition that would preclude informed consent
Additional tumor treatment between acquisition of tumor tissue and trial inclusion
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov